Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhGH (Jintrolong) Dose-Finding Study in Children with Turner Syndrome
NCT03189160Phase 2Unknown
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Mar 2016
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peg-somatropin in Turner syndrome (TS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
peg-somatropin
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT03189160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03189160.